XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash Flows from Operating Activities:              
Net income $ 1,272,198 $ 851,333 $ 2,985,788 $ 7,104,081 $ 2,123,531 $ 10,089,869  
Adjustments to reconcile net income to net cash used in operating activities:              
Interest earned on marketable securities held in Trust Account and Money Market (1,745,580)   (452,149)   (4,164,051) (547,651)  
Reduction of deferred underwriting fees 0   0   (297,062) 0  
Unrealized loss on marketable securities held in Trust Account         0 29,280  
Change in fair value of warrant liabilities         0 (10,676,250)  
Transaction cost incurred in connection with IPO 0   0   0 536,190 $ 536,190
Changes in operating assets and liabilities:              
Prepaid expenses         53,875 (320,183)  
Accrued expenses         1,688,025 277,216  
Net cash used in operating activities         (595,682) (611,529)  
Cash Flows from Investing Activities:              
Extension payments into the Trust Account         (428,338) (293,250,000)  
Cash withdrawn from Trust Account in connection with redemption         258,531,801 0  
Net cash provided by (used in) investing activities         258,103,463 (293,250,000)  
Cash Flows from Financing Activities:              
Proceeds from sale of Units, net of underwriting discounts paid         0 282,500,000  
Proceeds from sale of Private Placements Warrants         0 13,000,000  
Proceeds from advances from related party         385 0  
Repayment of advances from related party         (385) 0  
Proceeds from promissory note - related party         428,338 41,615  
Repayment of promissory note - related party         0 (250,115)  
Payment of offering costs         (70,000) (359,050)  
Redemption of ordinary shares         (258,531,801) 0  
Net cash (used in) provided by financing activities         (258,173,463) 294,932,450  
Net Change in Cash and Cash Equivalents         (665,682) 1,070,921  
Cash and cash equivalents - Beginning of period   $ 792,423   $ 158 792,423 158 158
Cash and cash equivalents - End of period $ 126,741   $ 1,071,079   126,741 1,071,079 $ 792,423
Non-Cash investing and financing activities:              
Offering costs included in accrued offering costs         0 70,000  
Change in value of Class A ordinary share subject to possible redemption         4,592,389 518,371  
Initial classification of Class A ordinary share subject to possible redemption         0 293,250,000  
Reduction of deferred underwriting fees         11,827,938 0  
Deferred underwriting fee payable         $ 0 $ 15,125,000